epigallocatechin gallate has been researched along with Cancer, Second Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felix, CA; Grimwade, D; Lindsey, RH; Osheroff, N; Pendleton, M | 1 |
| Brockmöller, J; Ettrich, T; Muche, R; Seeringer, A; Seufferlein, T; Stingl, JC; Wiedom, M | 1 |
1 review(s) available for epigallocatechin gallate and Cancer, Second Primary
| Article | Year |
|---|---|
Topoisomerase II and leukemia.
Topics: Animals; Antineoplastic Agents; Catechin; Cell Transformation, Neoplastic; Chromosome Breakage; Curcumin; DNA Topoisomerases, Type II; Genistein; Humans; Infant; Leukemia; Neoplasms, Second Primary; Translocation, Genetic | 2014 |
1 trial(s) available for epigallocatechin gallate and Cancer, Second Primary
| Article | Year |
|---|---|
Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.
Topics: Adenoma; Aged; Aged, 80 and over; Camellia sinensis; Catechin; Colonic Neoplasms; Colonoscopy; Dietary Supplements; Double-Blind Method; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Placebos; Plant Extracts | 2011 |